치매 및 인지장애에서의 신경심리평가

다국어 초록 (Multilingual Abstract)

Neuropsychological assessment is concerned with the behavioral expression of brain function through a series of cognitive testing tools. These results provide the objective identification of cognitive deficits, and play a key role in the detection of dementia and related cognitive disorders. New diagnostic guidelines for Alzheimer s disease (AD) and AD biomarker models suggest that cognitive declines are evidence of advanced neurodegenerative disease. Accordingly, the traditional contribution of neuropsychological assessment in early detection and diagnosis has been brought into question. In this review, the utility of neuropsychological assessment concerning dementia and cognitive disorders has been revisited. Neuropsychological assessment still plays a role in differential diagnosis as well as diagnosis. It is also useful to document cognitive changes along the dementia trajectory and to predict progression. Neuropsychological performance can estimate functional status and predict functional changes in everyday life. Identification of cognitive strengths and weaknesses can assist in intervention planning. However, the utility of neuropsychological assessment is not guaranteed if the neuropsychological tests have insufficient reliability, validity, and normative information. Commonly used cognitive screening tests and neuropsychological test batteries were examined. Lastly, several special considerations in the assessment of older adults were discussed

참고문헌 (Reference)

1 강연욱, "혈관성 인지장애 선별검사로서 Korean-Montreal Cognitive Assessment(K-MoCA)의 신뢰도, 타당도 및 규준 연구" 한국임상심리학회 28 (28): 549-562, 2009

2 석정서, "한국판 치매 평가 검사(K-DRS)의 2차 규준 연구" 한국임상심리학회 29 (29): 559-572, 2010

3 손은희, "한국판 Modified Mini-Mental State (K-3MS) Examination의 타당도" 대한신경과학회 21 (21): 4-356, 2003

4 이동영, "새로운 알츠하이머병 임상진단기준 : NIA-AA 진단가이드라인을 중심으로" 대한노인정신의학회 16 (16): 7-12, 2012

5 Smith GE, "plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?" 69 : 133-139, 2007

6 Fields JA, "Utility of the DRS for predicting problems in day-to-day functioning" 24 : 1167-1180, 2010

7 Sperling RA, "Toward defining the preclinical stages of Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease" 7 : 280-292, 2011

8 Seo EH, "Total scores of the CERAD neuropsychological assessment battery : validation for mild cognitive impairment and dementia patients with diverse etiologies" 18 : 801-809, 2010

9 Wouters H, "Three sides of the same coin: measuring global cognitive impairment with the MMSE, ADAS-cog and CAMCOG" 25 : 770-779, 2010

10 Desmond DW, "The neuropsychology of vascular cognitive impairment : is there a specific cognitive deficit?" 226 : 3-7, 2004

11 Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease" 7 : 270-279, 2011

12 McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease" 7 : 263-269, 2011

13 Stein J, "The assessment of changes in cognitive functioning : reliable change indices for neuropsychological instruments in the elderly-a systematic review" 29 : 275-286, 2010

14 Stuart-Hamilton I, "The Psychology of Ageing" Seoul National University Press 2017

15 Nasreddine ZS, "The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment" 53 : 695-699, 2005

16 Teng EL, "The Modified Mini-Mental State(3MS)examination" 48 : 314-318, 1987

17 Woo JI, "The Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K)" Seoul National University Press 2015

18 Cano SJ, "The ADAS-cog in Alzheimer’s disease clinical trials : psychometric evaluation of the sum and its parts" 81 : 1363-1368, 2010

19 Bilgel M, "Temporal order of Alzheimer’s disease-related cognitive marker changes in BLSA and WRAP longitudinal studies" 59 : 1335-1347, 2017

20 Kang Y, "Seoul neuropsychological screening battery" Human Brain Research & Consulting Co 2012

21 Kang Y, "Seoul neuropsychological screening battery" Human Brain Research & Consulting Co. 2003

22 안현정, "Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients" 대한의학회 25 (25): 1071-1076, 2010

23 Ritchie K, "Recommended cognitive outcomes in preclinical Alzheimer’s disease : consensus statement from the European Prevention of Alzheimer’s Dementia project" 13 : 186-195, 2017

24 Chen Y, "Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort" 13 : 399-405, 2017

25 Reed BR, "Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease" 130 (130): 731-739, 2007

26 Stuss DT, "Principles of frontal lobe function" Oxford University Press 2013

27 Jang H, "Prediction model of conversion to dementia risk in subjects with amnestic mild cognitive impairment: a longitudinal, multi-center clinic-based study" 60 : 1579-1587, 2017

28 Oulhaj A, "Predicting the time of conversion to MCI in the elderly : role of verbal expression and learning" 73 : 1436-1442, 2009

29 Marui W, "Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease" 108 : 121-128, 2004

30 Clark DG, "Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment" 2 : 113-122, 2016

31 Holden UP., "Neuropsychology and aging: definitions, explanations, and practical approaches" New York University Press 1988

32 Gallucci M, "Neuropsychological tools to predict conversion from amnestic mild cognitive impairment to dementia. The TREDEM Registry" 1-11, 2017

33 Blacker D, "Neuropsychological measures in normal individuals that predict subsequent cognitive decline" 64 : 862-871, 2007

34 Fields JA, "Neuropsychological assessment of patients with dementing illness" 7 : 677-687, 2011

35 Salmon DP, "Neuropsychological assessment of dementia" 60 : 257-282, 2009

36 Lezak MD, "Neuropsychological assessment" Oxford University Press 2012

37 Braak H, "Neuropathological stageing of Alzheimer-related changes" 82 : 239-259, 1991

38 이동영, "Mini-Mental State Examination의 한국 노인 정상규준 연구" 대한신경정신의학회 41 (41): 2002

39 Park JH, "Korean version of Mini-Mental State Examination (MMSE-K). Part I: development of the test for the elderly" 28 : 125-135, 1989

40 Tae Hui Kim, "Korean Version of Mini Mental Status Examination for Dementia Screening and Its Short Form" 대한신경정신의학회 7 (7): 102-108, 2010

41 American Educational Research Association, American Psychological Association, National Council on Measurment in Education, "Joint Committee on Standards for Educational and Psychological Testing. Standards for educational and psychological testing"

42 Weintraub S, "Is cognitive decline measurable in preclinical Alzheimer’s disease?" 13 : 322-323, 2017

43 Jack CR Jr, "Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease" 7 : 257-262, 2011

44 Johnson JK, "Executive function, more than global cognition, predicts functional decline and mortality in elderly women" 62 : 1134-1141, 2007

45 Grady CL, "Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer’s disease" 23 : 986-993, 2003

46 Chey J, "Effects of education in dementia assessment : evidence from standardizing the Korean-Dementia Rating Scale" 13 : 293-302, 1999

47 Karantzoulis S, "Distinguishing Alzheimer’s disease from other major forms of dementia" 11 : 1579-1591, 2011

48 Rascovsky K, "Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer’s disease" 21 : 20-30, 2007

49 American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders (DSM-5®)" American Psychiatric Association Pub 2013

50 Lee JH, "Development of the Korean version of the consortium to establish a registry for Alzheimer’s disease assessment packet(CERAD-K) : clinical and neuropsychological assessment batteries" 57 : 47-53, 2002

51 Youn JC, "Development of the Korean version of Alzheimer’s Disease Assessment Scale(ADAS-K)" 17 : 797-803, 2002

52 Yi D, "Development of the Korean Adult Reading Test (KART) to estimate premorbid intelligence in dementia patients" 12 : e0181523-, 2017

53 Mattis S., "Dementia Rating Scale: professional manual" Psychological Assessment Resources 1988

54 Nelson HE, "Dementia : the estimation of premorbid intelligence levels using the new adult reading test" 14 : 234-244, 1978

55 장승민, "Constructing a Composite Score for the Seoul Neuropsychological Screening Battery-Core" 대한치매학회 14 (14): 137-142, 2015

56 Mazzeo S, "Combining cerebrospinal fluid biomarkers and neuropsychological assessment : a simple and cost-effective algorithm to predict the progression from mild cognitive impairment to Alzheimer’s disease dementia" 54 : 1495-1508, 2016

57 Gluhm S, "Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan" 26 : 1-5, 2013

58 Schmitter-Edgecombe M, "Cognitive correlates of functional performance in older adults: comparison of self-report, direct observation, and performance-based measures" 17 : 853-864, 2011

59 Lee JY, "Brief screening for mild cognitive impairment in elderly outpatient clinic : validation of the Korean version of the Montreal Cognitive Assessment" 21 : 104-110, 2008

60 Hampel H, "Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives" 9 : 560-574, 2010

61 Biomarkers Definitions Working Group, "Biomarkers and surrogate endpoints : preferred definitions and conceptual framework" 69 : 89-95, 2001

62 Salmon DP, "Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals" 59 : 1022-1028, 2002

63 Li K, "Alzheimer’s Disease Neuroimaging Initiative. Prediction of conversion to Alzheimer’s disease with longitudinal measures and time-to-event data" 58 : 361-371, 2017

64 Seo EH, "Altered executive function in premild cognitive impairment" 54 : 933-940, 2016

65 O’Connell ME, "Age corrections and dementia classification accuracy" 25 : 126-138, 2010

66 In-Woong Kang, "Accuracy of Korean-Mini-Mental Status Examination Based on Seoul Neuro-Psychological Screening Battery II Results" 대한가정의학회 37 (37): 177-181, 2016

67 Weston PSJ, "Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer’s disease : a cross-sectional study" 17 : 123-132, 2018

68 Kang YW, "A validity study on the korean mini-mental state examination(K-MMSE)in dementia patients" 15 : 300-308, 1997

69 Seo EH, "A normative study of the Trail Making Test in Korean elders" 21 : 844-852, 2006

70 Lee DY, "A normative study of the CERAD neuropsychological assessment battery in the Korean elderly" 10 : 72-81, 2004

71 Rosen WG, "A new rating scale for Alzheimer’s disease" 141 : 1356-1364, 1984

72 Strauss E, "A compendium of neuropsychological tests: administration, norms, and commentary" Oxford University Press 2006

73 Folstein MF, ""Mini-mental state" : a practical method for grading the cognitive state of patients for the clinician" 12 : 189-198, 1975